News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Praveen Kumar Marimuthu: Pharmacovigilance alert in NSCLC
Praveen Kumar Marimuthu/X
May 20, 2025, 10:42

Praveen Kumar Marimuthu: Pharmacovigilance alert in NSCLC

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at the Christian Medical College and Hospital, shared an article on X:

“Pharmacovigilance alert in NSCLC!

PPIs plu Osimertinib is equal to Elevated Cardiotoxicity risk.

Postmarketing FAERS data links combo to:

  • QT prolongation
  • Cardiomyopathy
  • IHD
  • Arrhythmias
  • Heart failure
  • Avoid PPI.”

Praveen Kumar Marimuthu: Pharmacovigilance alert in NSCLC

Impact of Proton Pump Inhibitors on Osimertinib-Induced Cardiotoxicity in NSCLC Patients.

Authors: Haitao Wang, Sinan Ma, Weijia Huang, Keyu Chen, Jiao Xie, Na Wang, Youjia Li, Qianting Yang, Xin Yang, and Yan Wang.

You can read the full article on Journal of Springer Nature Link.

Praveen Kumar Marimuthu: Pharmacovigilance alert in NSCLC

More posts featuring Praveen Kumar Marimuthu.

Arrhythmias cancer Cardiomyopathy Christian Medical College and Hospital FAERS data fight against cancer Global fight against cancer Haitao Wang Jiao Xie Keyu Chen Na Wang NSCLC OncoDaily Oncology osimertinib Pharmacovigilance PPIs Praveen Kumar Marimuthu Qianting Yang Sinan Ma Springer Nature Link Weijia Huang Xin Yang Yan Wang Youjia Li
Special Coverage
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH
Insight
Aug 21, 2025, 11:16
Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients
Voices
Aug 21, 2025, 11:15
Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...
OncoDaily Pulse
Aug 21, 2025, 10:23
Archana Ajmera: Meet the Experts of VIRO 2025
OncoDaily Pulse
Aug 21, 2025, 10:08
Yüksel Ürün: Meet the Experts of VIRO 2025
Voices
Aug 21, 2025, 09:46
Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 09:30
Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML